Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - February 7, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for 2022. Commercial highlights QUVIVIQ
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - February 6, 2023 Idorsia Ltd (SIX: IDIA) today announces the initial findings of REACT, a Phase 3 study which investigated the
The application includes data from the Phase 3 registration study of patients with resistant hypertension, where aprocitentan demonstrated a sustained blood pressure reduction over 48 weeks and was well-tolerated Allschwil
Idorsia will publish its full year financial results 2022 on Tuesday February 7, 2023, at 07:00 CET An investor conference call and webcast will be held to discuss the results on the same day. Date:
Idorsia will publish its full year financial results 2022 on Tuesday February 7, 2023, at 07:00 CET An investor conference call and webcast will be held to discuss the results on the same day. . | January 31, 2023